Cargando…

Reply to ‘Comment on ‘Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system”

Detalles Bibliográficos
Autores principales:	Bae, Jeong Mo, Kim, Jung Ho, Kwak, Yoonjin, Lee, Dae-Won, Cha, Yongjun, Wen, Xianyu, Lee, Tae Hun, Cho, Nam-Yun, Jeong, Seung-Yong, Park, Kyu Joo, Han, Sae Won, Lee, Hye Seung, Kim, Tae-You, Kang, Gyeong Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808037/ https://www.ncbi.nlm.nih.gov/pubmed/29384526 http://dx.doi.org/10.1038/bjc.2017.426

Ejemplares similares

Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system
por: Bae, Jeong Mo, et al.
Publicado: (2017)

Comment on ‘Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system’
por: Tapial, Sandra, et al.
Publicado: (2018)

Distinct epigenetic signatures elucidate enhancer-gene relationships that delineate CIMP and non-CIMP colorectal cancers
por: Chong, Allen, et al.
Publicado: (2016)

18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high
por: Ogino, Shuji, et al.
Publicado: (2007)

Expression and regulatory roles of lncRNAs in G-CIMP-low vs G-CIMP-high Glioma: an in-silico analysis
por: Datta, Indrani, et al.
Publicado: (2021)

Survival differences of CIMP subtypes integrated with CNA information in human breast cancer
por: Wang, Huihan, et al.
Publicado: (2017)

Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas
por: Li, Jie, et al.
Publicado: (2014)

The Emergence of Pan-Cancer CIMP and Its Elusive Interpretation
por: Miller, Brendan F., et al.
Publicado: (2016)

The CpG island methylator phenotype (CIMP) in colorectal cancer
por: Mojarad, Ehsan Nazemalhosseini, et al.
Publicado: (2013)

External validation of molecular subtype classifications of colorectal cancer based on microsatellite instability, CIMP, BRAF and KRAS
por: Alwers, Elizabeth, et al.
Publicado: (2019)

cIMP: Synthesis, effector activation, inactivation and occurrence in biological systems
por: Seifert, Roland, et al.
Publicado: (2015)

Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas
por: Yin, An-An, et al.
Publicado: (2019)

The CIMP-high phenotype is associated with energy metabolism alterations in colon adenocarcinoma
por: Fedorova, Maria S., et al.
Publicado: (2019)

Development and validation of a CIMP-associated prognostic model for hepatocellular carcinoma
por: Li, Ganxun, et al.
Publicado: (2019)

CIMP-positive glioma is associated with better prognosis: A systematic analysis
por: Xu, Yingying, et al.
Publicado: (2022)

Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma
por: Krause, Lutz, et al.
Publicado: (2016)

Multiregional assessment of CIMP in primary colorectal cancers: Phenotype concordance but marker variability
por: Flatin, Bjørnar T.B., et al.
Publicado: (2020)

G-Cimp Status Prediction Of Glioblastoma Samples Using mRNA Expression Data
por: Baysan, Mehmet, et al.
Publicado: (2012)

Hypoxic Vasospasm Mediated by cIMP: When Soluble Guanylyl Cyclase Turns Bad
por: Gao, Yuansheng, et al.
Publicado: (2015)

Analysis of the Association between CIMP and BRAF(V600E) in Colorectal Cancer by DNA Methylation Profiling
por: Hinoue, Toshinori, et al.
Publicado: (2009)

The CIMP Phenotype in BRAF Mutant Serrated Polyps from a Prospective Colonoscopy Patient Cohort
por: Fernando, Winnie C., et al.
Publicado: (2014)

A five‐CpG signature of microRNA methylation in non‐G‐CIMP glioblastoma
por: Kang, En‐Ming, et al.
Publicado: (2019)

LINE-1 hypomethylation in human hepatocellular carcinomas correlates with shorter overall survival and CIMP phenotype
por: Anwar, Sumadi Lukman, et al.
Publicado: (2019)

Integrative analysis identifies an immune-relevant epigenetic signature for prognostication of non-G-CIMP glioblastomas
por: Yin, Anan, et al.
Publicado: (2021)

A Novel Pseudogene Methylation Signature to Predict Temozolomide Outcome in Non-G-CIMP Glioblastomas
por: Li, Bowen, et al.
Publicado: (2022)

Cimp-Positive Status is More Representative in Multiple Colorectal Cancers than in Unique Primary Colorectal Cancers
por: Tapial, Sandra, et al.
Publicado: (2019)

Unique characteristics of CpG island methylator phenotype (CIMP) in a Chinese population with colorectal cancer
por: Liu, Jiang, et al.
Publicado: (2019)

Body Size, Physical Activity and Risk of Colorectal Cancer with or without the CpG Island Methylator Phenotype (CIMP)
por: Hughes, Laura A. E., et al.
Publicado: (2011)

Trends and applications in software engineering: proceedings of the 8th international conference on software process improvement (CIMPS 2019)
por: Mejia, Jezreel, et al.
Publicado: (2019)

The cyclic nucleotide 3’,5’-cIMP produced by sGC is a second messenger in the vascular wall
por: Vanhoutte, Paul M, et al.
Publicado: (2015)

DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis
por: Tögel, Lars, et al.
Publicado: (2018)

Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer
por: McInnes, Tyler, et al.
Publicado: (2017)

DNMT3B Oncogenic Activity in Human Intestinal Cancer Is Not Linked to CIMP or BRAFV600E Mutation
por: MacKenzie, Douglas J., et al.
Publicado: (2020)

Fibroblast Growth Factor Receptor 1 (FGFR1) Amplification Detected by Droplet Digital Polymerase Chain Reaction (ddPCR) Is a Prognostic Factor in Colorectal Cancers
por: Bae, Jeong Mo, et al.
Publicado: (2020)

SOCS3 Promoter Hypermethylation Is a Favorable Prognosticator and a Novel Indicator for G-CIMP-Positive GBM Patients
por: Feng, Ying, et al.
Publicado: (2014)

Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy
por: Murcia, Oscar, et al.
Publicado: (2018)

Clinicopathological and Molecular Profiles of Sporadic Microsatellite Unstable Colorectal Cancer with or without the CpG Island Methylator Phenotype (CIMP)
por: Chang, Shih-Ching, et al.
Publicado: (2020)

Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP)
por: Ricketts, Christopher J., et al.
Publicado: (2022)

Author Correction: DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis
por: Tögel, Lars, et al.
Publicado: (2023)

Impact of IDH Mutations, the 1p/19q Co-Deletion and the G-CIMP Status on Alternative Splicing in Diffuse Gliomas
por: Zhang, Lu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sgpepidjmgou4vdssfruc15ndq